CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
133 hedge funds and large institutions have $485M invested in Cymabay Therapeutics in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 29 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
-9
Holders Change %
-6.34%
% of All Funds
2.89%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
25
Increased
54
Reduced
29
Closed
32
Calls
$7.81M
Puts
$1.28M
Net Calls
+$6.53M
Net Calls Change
+$5.77M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$27.9M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
$19.3M |
| 3 |
Millennium Management
New York
|
$21.4M |
| 4 |
Citigroup
New York
|
$4.17M |
| 5 |
BlackRock
New York
|
$39.6M |
